Houghton Mifflin Harcourt Company (NASDAQ:HMHC) does about 5.03M shares in volume on a normal day but saw 2876194 shares change hands in Tuesday trading. The company now has a market cap of 275.78M USD and an enterprise value of about $1.04B. Its current market price is $2.29, marking an increase of 1.33% compared to the previous close of $2.26. The 52 week high reached by this stock is $6.85 whilst the lowest price level in 52 weeks is $1.03. The script in recent trading has seen the stock touch a high of $2.35 and a low of $2.18.
Houghton Mifflin Harcourt Company (HMHC) has a 20-day trading average at $2.56 and the current price is -66.57% off the 52-week high compared with 122.33% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.29 and its 200-day simple moving average is $3.52. If we look at the stock’s price movements over the week, volatility stands at 10.88%, which decreases to 10.36% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 47.31 to suggest the stock is neutral.
5 analysts observing the Houghton Mifflin Harcourt Company (HMHC) stock have set the 12-month price targets for the company’s shares at between $1.00 and $5.00. The consensus objective for the share price is $2.90, suggesting that the stock has a potential upside of 21.03% over the period. The median price target is 23.67% away from the current levels at $3.00.
FactSet Research has provided data showing that 5 brokerages have issued ratings for the stock. 1 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 3 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 07, 2020 when BMO Capital Markets downgraded the stock to “Market Perform” and issued a price target of between $7 and $3. Citigroup also downgraded the stock to “Sell” from Buy on April 03, 2020 at a price target of $7.50-$1.
The current price level is -12.04%, 0.16%, and -35.26% away from its SMA20, SMA50, and SMA200 respectively, with the HMHC price moving above the 50-day SMA on September 01. Houghton Mifflin Harcourt Company (HMHC) stock is up 4.57% over the week and -21.58% over the past month. Its price is -63.36% year-to-date and -60.52% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.3 below consensus estimates by $0. The company’s next earnings report is expected on 10/29/2020, with forecasts estimating quarterly EPS at $0.55 and -$3.09 for whole year. HMHC’s earnings per share are forecast to shrink by -91.90% this year and 74.80% over next year. Expected sales for next quarter are $228.62 million, which analysts say will come at $1.17 billion for the current fiscal year and next year at $1.26 billion. In addition, estimates put the company’s current quarterly revenue at an average of $502.81 million.
Its 12-month price target is $3.00. To reach the target analysts have set, the stock logically needs to grow 21.03 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $1.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $5.00.
Outstanding shares total 125.46M with insiders holding 0.71% of the shares and institutional holders owning 99.12% of the company’s common stock. The company has a return on investment of -13.70% and return on equity of -105.60%. The beta has a value of 1.36. Price to book ratio is 1.52 and price to sales ratio is 0.22.
According to a U.S. Securities and Exchange Commission filing, Vanguard Explorer Fund has reduced its position in Houghton Mifflin Harcourt Company (HMHC) to 7,198,968 shares, mirroring a recent drop by 0.00%. Vanguard Explorer Fund dumped 0.0 shares of Houghton Mifflin Harcourt Company common stock bringing its total worth to about $21.31 million at the end of recent close, SEC documents show. Vanguard Explorer Fund isn’t the only investment manager who changed stakes and is followed by Vanguard Total Stock Market Index, which sold off 0.0 shares to end up with 3,097,144 shares worth $9.17 million. iShares Russell 2000 ETF cut their holdings by -4.47% in the company over the course of the most recent quarter. It now holds a 1.70% position in Houghton Mifflin Harcourt Company thanks to 2.14 million shares amounting to $6.32 million.